Department of Inflammation and Oncology Research, Amgen, South San Francisco, CA 94080, USA.
Laboratory of Immunoregulation and Infection, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Immunity. 2019 Apr 16;50(4):871-891. doi: 10.1016/j.immuni.2019.03.020.
Cytokines are among the most important effector and messenger molecules in the immune system. They profoundly participate in immune responses during infection and inflammation, protecting against or contributing to diseases such as allergy, autoimmunity, and cancer. Manipulating cytokine pathways, therefore, is one of the most effective strategies to treat various diseases. IL-10 family cytokines exert essential functions to maintain tissue homeostasis during infection and inflammation through restriction of excessive inflammatory responses, upregulation of innate immunity, and promotion of tissue repairing mechanisms. Their important functions in diseases are supported by data from many preclinical models, human genetic studies, and clinical interventions. Despite significant efforts, however, there is still no clinically approved therapy through manipulating IL-10 family cytokines. Here, we summarize the recent progress in understanding the biology of this family of cytokines, suggesting more specific strategies to maneuver these cytokines for the effective treatment of inflammatory diseases and cancers.
细胞因子是免疫系统中最重要的效应分子和信使分子之一。它们在感染和炎症期间的免疫反应中发挥着深远的作用,既能预防也能导致过敏、自身免疫和癌症等疾病。因此,操纵细胞因子途径是治疗各种疾病最有效的策略之一。IL-10 家族细胞因子通过限制过度的炎症反应、上调先天免疫和促进组织修复机制,在感染和炎症过程中发挥维持组织内稳态的重要功能。许多临床前模型、人类遗传研究和临床干预的数据支持了它们在疾病中的重要作用。然而,尽管付出了巨大的努力,仍然没有通过操纵 IL-10 家族细胞因子而获得临床批准的治疗方法。在这里,我们总结了对该家族细胞因子生物学的最新认识,提出了更具体的操纵这些细胞因子的策略,以有效治疗炎症性疾病和癌症。